OIS@AAO 2014 Videos
ForSight VISION5 Inc. CEO John Maroney discussed his company’s novel, non-invasive insert system, Helios. Placed on the surface of the eye, under the eyelid, Helios…
Read MoreImplandata Ophthalmic Products GmbH is developing a patient-operated, hand-held system, which works with an implantable micro sensor capable of measuring absolute intraocular pressure continuously or…
Read MoreMati Therapeutics Inc. is an early-stage company addressing the massive glaucoma market. Founder and CEO Robert Butchofsky discussed the main challenges to all glaucoma-focused sustained…
Read MorePowerVision Inc.’s FluidVision, an intraocular lens designed to treat presbyopia and/or cataracts, is the only technology that restores true accommodation, reported company President and CEO…
Read MoreTearScience Inc. CEO and Co-Founder Tim Willis emphasized that his company was founded for a single reason: to be the evaporative dry eye expert, and…
Read MoreWaveTec Vision Systems ORA system is the first intra-operative diagnostic tool on the market to enhance visual outcomes in cataract surgery. It allows surgeons, in…
Read MoreAlimera Sciences Inc. is ready to launch in the US its recently approved intravitreal implant, Iluvien, for treating diabetic macular edema. President and CEO Dan…
Read MoreMC2 Biotek Group’s Co-Founder and President Jesper J. Lange updated attendees on the company’s PAD technology, which may make existing drugs easier to use. The…
Read More
SUBSCRIBE TO OIS NEWS
Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.
We respect your privacy and promise to never send you spam.
![OIS-ANTERIOR-NEW-DATE-750x420[4300]](https://ois.net/wp-content/uploads/2020/03/OIS-ANTERIOR-NEW-DATE-750x4204300.jpg "OIS-ANTERIOR-NEW-DATE-750x420[4300]")